Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$615K Buy
286,205
+55,946
+24% +$191K ﹤0.01% 3901
2025
Q3
$1.11M Buy
230,259
+13,424
+6% +$73.3K ﹤0.01% 3760
2025
Q2
$1.2M Sell
216,835
-1,224
-0.6% -$9.68K ﹤0.01% 3693
2025
Q1
$2.68M Buy
218,059
+568
+0.3% +$8.67K ﹤0.01% 3389
2024
Q4
$2.91M Buy
217,491
+686
+0.3% +$7.8K ﹤0.01% 3454
2024
Q3
$2.03M Buy
216,805
+4,505
+2% +$45.6K ﹤0.01% 3554
2024
Q2
$2.06M Buy
212,300
+5,775
+3% +$57.1K ﹤0.01% 3545
2024
Q1
$2.17M Buy
206,525
+5,605
+3% +$69.3K ﹤0.01% 3568
2023
Q4
$2.68M Buy
200,920
+2,644
+1% +$36.2K ﹤0.01% 3496
2023
Q3
$2.87M Buy
198,276
+781
+0.4% +$13.4K ﹤0.01% 3471
2023
Q2
$3.89M Buy
197,495
+19,373
+11% +$304K ﹤0.01% 3424
2023
Q1
$2.9M Buy
178,122
+2,020
+1% +$31.2K ﹤0.01% 3543
2022
Q4
$1.84M Buy
176,102
+32,500
+23% +$288K ﹤0.01% 3687
2022
Q3
$765K Sell
143,602
-50,570
-26% -$381K ﹤0.01% 4080
2022
Q2
$1.74M Sell
194,172
-115,511
-37% -$1.34M ﹤0.01% 3862
2022
Q1
$5.48M Sell
309,683
-77,730
-20% -$2.42M ﹤0.01% 3482
2021
Q4
$22M Sell
387,413
-54,539
-12% -$3.64M ﹤0.01% 2786
2021
Q3
$33.3M Buy
441,952
+84,263
+24% +$8.92M ﹤0.01% 2589
2021
Q2
$60.1M Sell
357,689
-85,127
-19% -$14.9M ﹤0.01% 2262
2021
Q1
$77.6M Buy
442,816
+196,479
+80% +$39.6M ﹤0.01% 2086
2020
Q4
$50.5M Buy
246,337
+2,979
+1% +$553K ﹤0.01% 2197
2020
Q3
$47.5M Buy
+243,358
New +$58.6M ﹤0.01% 2038

Other funds holding GOCO

Vanguard Group's GOCO Position: Q4 2025 in Review

Vanguard Group increased its GoHealth (GOCO) stake by 24% in Q4 2025, buying an estimated $191K and bringing the position to 286,205 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #3901.

Vanguard Group first reported a position in GOCO in Q3 2020 and has held it in 22 quarters since. The position peaked at $77.6M in Q1 2021. 56 funds tracked by Wall St. Rank hold GOCO as of Q4 2025.

  • Vanguard Group held 286,205 shares of GoHealth worth $615K as of Q4 2025.
  • Vanguard Group bought 55,946 GoHealth shares in Q4 2025, an estimated $191K.
  • GoHealth made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3901 holding.
  • Vanguard Group first reported a position in GoHealth in Q3 2020 and has held it in 22 quarters since.
  • Vanguard Group's GoHealth position peaked at $77.6M in Q1 2021.
  • 56 funds tracked by Wall St. Rank held GoHealth as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.